M&A Deal Summary

Multek Acquires Sheldahl

On August 16, 2004, Multek acquired semiconductors company Sheldahl from MPE Partners and Ampersand Capital Partners

Acquisition Highlights
  • This is Multek’s 1st transaction in the Semiconductors sector.
  • This is Multek’s 1st transaction in the United States.
  • This is Multek’s 1st transaction in Minnesota.

M&A Deal Summary

Date 2004-08-16
Target Sheldahl
Sector Semiconductors
Buyer(s) Multek
Sellers(s) MPE Partners
Ampersand Capital Partners
Deal Type Add-on Acquisition

Target

Sheldahl

Northfield, Minnesota, United States
Sheldahl, Inc. is a Producer of high-density substrates, high quality flexible printed circuitry and flexible laminates.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Multek

Northfield, Minnesota, United States

Category Company
Founded 1978
Sector Semiconductors
DESCRIPTION

Multek Corp. is a manufacturer of PCB technologies offering a broad spectrum of PCB engineering and manufacturing expertise. Multek enables customers to take products to market quickly through advanced technology production and a full range of high performance materials.


DEAL STATS #
Overall 1 of 1
Sector (Semiconductors) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 1 of 1
Year (2004) 1 of 1

Seller(S) 2

SELLER

MPE Partners

Cleveland, Ohio, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1968
PE ASSETS 3.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

MPE Partners is a Midwest based investment firm principally focused private equity investments throughout North America. MPE has a preference for buyouts and recapitalizations of lower middle-market, family and entrepreneur owned businesses. The Firm looks for stand-alone companies operating in the 'high-value' manufacturing or business services sectors. MPE seeks businesses with at least $5 million of EBITDA and valued up to $250 million. MPE Partners is headquartered in Cleveland, Ohio.


DEAL STATS #
Overall 16 of 58
Sector (Semiconductors) 3 of 5
Type (Add-on Acquisition) 9 of 27
State (Minnesota) 1 of 2
Country (United States) 15 of 56
Year (2004) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-02-25 rePipe

Houston, Texas, United States

rePipe, Inc. is a provider of underground construction and pipe rehabilitation services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-08-23 Precision Parts International

Rochester Hills, Michigan, United States

Precision Parts International LLC is a manufacturer of high-precision, complex metal components using fineblanking, high-precision gearing and stamping processes.

Buy -
SELLER

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 4 of 55
Sector (Semiconductors) 1 of 1
Type (Add-on Acquisition) 2 of 38
State (Minnesota) 1 of 3
Country (United States) 4 of 51
Year (2004) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-08-12 Stereotaxis

St. Louis, Missouri, United States

Stereotaxis is a medical device company that markets a magnetic control system with applications in electrophysiology, interventional cardiology and interventional neuroradiology. Stereotaxis was founded in 1990 and is based in St. Louis, Missouri.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-10-19 Magellan Biosciences

Chelmsford, Massachusetts, United States

Magellan Biosciences, Inc. is a developer and manufacturer of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults.

Buy -